Full-Time
Associate Engineer
Quality
Posted on 5/15/2025
Stryker
10,001+ employees
Develops and manufactures medical devices and equipment
No salary listed
Entry
Limerick, Ireland
- Diploma or equivalent in Engineering, Science or related subject
- In active Education to a Bachelor degree in Science, Engineering or equivalent/ related subject
- 0+ years experience in a manufacturing environment or equivalent.
- Work closely with operations and the business functions to ensure quality performance of product and processes.
- Collaborates with Divisional QA, cross-functional and suppliers teams to address top quality issues.
- Own identified internal and supplier driven non-conformances and manage the timely closure of NC's within.
- Own or support identified internal CAPAs and manage to timely root cause investigation, implementation and closure.
- Disposition non-conforming product within MRB, issuing NC's as appropriate.
- Communicate with suppliers regarding non-conformances, escalating supplier corrective action requests as required.
- Engage in the development and improvement of the internal manufacturing processes for existing products.
- Performs critical assessment of internal and supplier proposed change management activities.
- Participates in the creation and/or review of new or modified procedures.
- Maintain KPIs for monitoring of process and/or product quality, perform analysis, and interpret trends, identifying and activating on appropriate actions as necessary.
- Support execution and analysis of manufacturing related complaints and product field actions.
Stryker develops and manufactures medical devices and equipment aimed at improving patient care and surgical efficiency. Their product range includes surgical tools, neurotechnology, and orthopedic implants, which are sold directly to hospitals and clinics worldwide. Stryker stands out from competitors by focusing on high-quality products and a commitment to advancing healthcare solutions. The company's goal is to enhance the overall healthcare experience for both patients and medical professionals.
Company Size
10,001+
Company Stage
IPO
Headquarters
Kalamazoo, Michigan
Founded
1941
Simplify's Take
What believers are saying
- Growing demand for minimally invasive solutions aligns with Stryker's strategic acquisitions.
- The orthopedic implants market growth benefits Stryker's expanding product line.
- Stryker's acquisition of Inari Medical positions it in a high-growth vascular market.
What critics are saying
- Integration challenges from acquisitions may strain Stryker's resources.
- Rapid tech advancements risk obsolescence of Stryker's current products.
- Regulatory scrutiny on acquisitions could delay Stryker's market entry.
What makes Stryker unique
- Stryker's acquisitions enhance its minimally invasive surgical solutions portfolio.
- Entry into the peripheral vascular segment diversifies Stryker's market presence.
- Stryker's focus on AI integration boosts diagnostic accuracy and operational efficiency.
Help us improve and share your feedback! Did you find this helpful?
Benefits
Medical & prescription plans
Supplemental health benefits
Flexible Spending accounts
Employee Assistance Program
Short-term & long-term disability
Tuition reimbursement
401(k) plan
Employee Stock Purchase Plan
Company News
Portage, Michigan and Irvine, California, Jan. 06, 2025 (GLOBE NEWSWIRE) -- Stryker (NYSE: SYK), a global leader in medical technologies, announced...
/PRNewswire/ -- Stryker (NYSE: SYK), a global leader in medical technologies, announced today that it has completed the acquisition of NICO Corporation, a...
Stryker has announced a definitive agreement to acquire Vertos Medical, a privately held company providing a minimally invasive solution.
Stryker has announced a definitive agreement to acquire care.ai.
Stryker (NYSE:SYK) has completed the acquisition of MOLLI Surgical Inc., a company specializing in wire-free soft tissue localization technology for breast conserving surgery. The MOLLI 2 localization system enhances surgical workflow with its small 3.2 mm marker and real-time feedback. This acquisition strengthens Stryker's breast cancer care portfolio, complementing its existing SPY fluorescence imaging technology. For more information, visit www.stryker.com.